These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22910039)

  • 21. An ERG channel inhibitor from the scorpion Buthus eupeus.
    Korolkova YV; Kozlov SA; Lipkin AV; Pluzhnikov KA; Hadley JK; Filippov AK; Brown DA; Angelo K; Strøbaek D; Jespersen T; Olesen SP; Jensen BS; Grishin EV
    J Biol Chem; 2001 Mar; 276(13):9868-76. PubMed ID: 11136720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and evaluation of substituted piperidine based KCNQ openers as novel antiepileptic agents.
    Yang S; Lu D; Ouyang P
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1731-1735. PubMed ID: 29706422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
    Hadley JK; Noda M; Selyanko AA; Wood IC; Abogadie FC; Brown DA
    Br J Pharmacol; 2000 Feb; 129(3):413-5. PubMed ID: 10711337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation.
    Guo J; Wang T; Yang T; Xu J; Li W; Fridman MD; Fisher JT; Zhang S
    J Biol Chem; 2011 Oct; 286(40):34664-74. PubMed ID: 21844197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.
    Choi SH; Shin TJ; Lee BH; Chu DH; Choe H; Pyo MK; Hwang SH; Kim BR; Lee SM; Lee JH; Kim DH; Kim HC; Rhim HW; Nah SY
    Eur J Pharmacol; 2010 Jul; 637(1-3):138-47. PubMed ID: 20399767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing binding sites and mechanisms of action of an I(Ks) activator by computations and experiments.
    Xu Y; Wang Y; Zhang M; Jiang M; Rosenhouse-Dantsker A; Wassenaar T; Tseng GN
    Biophys J; 2015 Jan; 108(1):62-75. PubMed ID: 25564853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.
    Wang K; McIlvain B; Tseng E; Kowal D; Jow F; Shen R; Zhang H; Shan QJ; He L; Chen D; Lu Q; Dunlop J
    Assay Drug Dev Technol; 2004 Oct; 2(5):525-34. PubMed ID: 15671650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
    Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
    Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A constitutively open potassium channel formed by KCNQ1 and KCNE3.
    Schroeder BC; Waldegger S; Fehr S; Bleich M; Warth R; Greger R; Jentsch TJ
    Nature; 2000 Jan; 403(6766):196-9. PubMed ID: 10646604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of basolateral small conductance potassium channels (KCNQ1/KCNE3) in ulcerative colitis.
    Al-Hazza A; Linley J; Aziz Q; Hunter M; Sandle G
    Biochem Biophys Res Commun; 2016 Feb; 470(2):473-478. PubMed ID: 26718405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New highly potent and selective adenosine A(3) receptor antagonists.
    Press NJ; Keller TH; Tranter P; Beer D; Jones K; Faessler A; Heng R; Lewis C; Howe T; Gedeck P; Mazzoni L; Fozard JR
    Curr Top Med Chem; 2004; 4(8):863-70. PubMed ID: 15078217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter.
    Lerche C; Bruhova I; Lerche H; Steinmeyer K; Wei AD; Strutz-Seebohm N; Lang F; Busch AE; Zhorov BS; Seebohm G
    Mol Pharmacol; 2007 Jun; 71(6):1503-11. PubMed ID: 17347319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy.
    Yang WP; Levesque PC; Little WA; Conder ML; Ramakrishnan P; Neubauer MG; Blanar MA
    J Biol Chem; 1998 Jul; 273(31):19419-23. PubMed ID: 9677360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
    Zhang D; Thimmapaya R; Zhang XF; Anderson DJ; Baranowski JL; Scanio M; Perez-Medrano A; Peddi S; Wang Z; Patel JR; DeGoey DA; Gopalakrishnan M; Honore P; Yao BB; Surowy CS
    J Neurosci Methods; 2011 Aug; 200(1):54-62. PubMed ID: 21723881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle.
    Ohya S; Asakura K; Muraki K; Watanabe M; Imaizumi Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G277-87. PubMed ID: 11804849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists.
    Hayashi R; Ohmori E; Moriwaki M; Kumagai H; Isogaya M
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3921-3. PubMed ID: 26238322
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.